DNAマイクロアレイの世界市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測（2025年～2030年）

DNAマイクロアレイ市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のDNAマイクロアレイの市場規模は、2025年～2030年にCAGR8.8％を記録し、2030年には35億3,000万米ドルに達すると予測されています。

DNAマイクロアレイ市場は、主要参入企業による技術の進歩や研究開発投資の増加により、飛躍的な成長機会が見込まれます。加えて、遺伝病診断、がん研究、個別化医療などの様々な用途でDNAマイクロアレイ技術の採用が増加していることが、世界市場を推進する主要因となっています。

迅速かつ正確な疾患診断は、患者の適切な治療にとって非常に重要です。分子レベルの相互作用と検出技術における最近の進歩は、診断のための新しいソリューションを提供することで、臨床診断サービスをアップグレードしています。同様に、診断用DNAマイクロアレイの最近の進歩は、市場の利害関係者に新たな道を開いています。DNAマイクロアレイ技術は、ジェノタイピング、疾病診断、異常検出、塩基多型のスクリーニングに応用されています。

さらに、世界のDNAマイクロアレイ市場は、研究資金の増加、医療費の上昇、技術の進歩、精密でオーダーメイドの治療ソリューションに対する需要の増加により、飛躍的な成長機会を見つけると予測されています。例えば、Med City INVEST Precision Medicineによると、慢性疾患治療のための精密治療を含む特定の治療法に対する消費者の認識が高まっています。

加えて、効果的で先進的な診断ツールの製造に向けた大手企業による投資の増加や、市場参入企業によるさまざまな戦略的取り組みが、新たな拡大路線を生み出す可能性が高いです。例えば、2022年9月、Illumina, Inc.は、年間2万以上のゲノムを生産できる次世代技術製品NovaSeq Xシリーズの発売を発表しました。さらに2021年9月には、ショット・ミニファブがアリゾナ州を拠点とするマイクロアレイソリューション会社を買収しました。この買収により、米国におけるバイオサイエンス機能の強化が期待されます。

DNAマイクロアレイ市場レポートのハイライト

• オリゴヌクレオチドDNAマイクロアレイは、費用対効果が高く、ゲノム中のすべての遺伝子の発現をモニターできることから、最大シェアを占めています。
• 相補的DNAマイクロアレイセグメントは、多型スクリーニング、ゲノムDNAクローンマッピング、遺伝子発見など幅広い用途があるため、最も速い成長率を記録すると予測されています。
• 遺伝子発現解析セグメントは、臨床診断、創薬、微生物学、その他の最終用途などのさまざまな用途で遺伝子発現が採用されているため、2024年に最大の市場を占めました。
• 最終用途別では、学術・研究機関セグメントが2024年の市場を独占し、診断センターセグメントが予測期間中に最も急成長すると予測されています。
• アジア太平洋は、ゲノム研究資金の急増と遺伝子検査に対する意識の高まりにより、予測期間中に最も速い成長を示すと予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 DNAマイクロアレイ市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 浸透と成長の見通しマッピング
• DNAマイクロアレイ：市場分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTLE分析
• 規制の枠組み

第4章 DNAマイクロアレイ市場セグメント分析：タイプ別（2018年～2030年）

• 定義と範囲
• タイプの市場シェア分析（2022年・2030年）
• セグメントダッシュボード
• 世界のDNAマイクロアレイ市場：タイプ別（2018年～2030年）
• 市場規模と予測および動向分析（2018年～2030年）
  • 相補的DNAマイクロアレイ
  • オリゴヌクレオチドDNAマイクロアレイ

第5章 DNAマイクロアレイ市場セグメント分析：用途別（2018年～2030年）

• 定義と範囲
• 用途の市場シェア分析（2022年・2030年）
• セグメントダッシュボード
• 世界のDNAマイクロアレイ市場：用途別（2018年～2030年）
• 市場規模と予測および動向分析（2018年～2030年）
  • 遺伝子発現解析
  • ジェノタイピング
  • その他

第6章 DNAマイクロアレイ市場セグメント分析：最終用途別（2018年～2030年）

• 定義と範囲
• 最終用途の市場シェア分析（2022年・2030年）
• セグメントダッシュボード
• 世界のDNAマイクロアレイ市場：最終用途別（2018年～2030年）
• 市場規模と予測および動向分析（2018年～2030年）
  • 製薬・バイオテクノロジー企業
  • 診断センター
  • 病院と診療所
  • 学術・研究機関
  • その他

第7章 DNAマイクロアレイ市場セグメント分析：地域別（2018年～2030年）

• 定義と範囲
• 地域別市場シェア分析（2022年・2030年）
• 地域市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• 市場規模、予測、収益、動向分析（2022年～2030年）
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 DNAマイクロアレイ市場：競合分析

• 主要市場参入企業による最近の動向と影響分析
  • アンゾフの成長マトリックス
  • ヒートマップ分析
  • 主要取引と戦略的提携分析
• 企業分類
  • イノベーター
  • マーケットリーダー
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • 主要顧客
• 公開企業
  • 競合ダッシュボード分析
• 非公開企業
  • 主要新興企業リスト
• 企業プロファイル
  • QIAGEN
  • Illumina, Inc.
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • BIOMERIEUX
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • Applied Micro Arrays

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Leading Market Players Anticipated to Witness Highest Growth
• Table 4 Global DNA Microarray Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 6 Global DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 7 Global DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 8 North America DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
• Table 9 North America DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 10 North America DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 11 North America DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 12 U.S. DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 13 U.S. DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 14 U.S. DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 15 Canada DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 16 Canada DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 17 Canada DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 18 Mexico DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 19 Mexico DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 20 Mexico DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 21 Europe DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
• Table 22 Europe DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 23 Europe DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 24 Europe DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 25 Germany DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 26 Germany DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 27 Germany DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 28 UK DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 29 UK DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 30 UK DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 31 France DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 32 France DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 33 France DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 34 Spain DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 35 Spain DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 36 Spain DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 37 Italy DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 38 Italy DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 39 Italy DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 40 Denmark DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 41 Denmark DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 42 Denmark DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 43 Norway DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 44 Norway DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 45 Norway DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 46 Sweden DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 47 Sweden DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 48 Sweden DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 53 Japan DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 54 Japan DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 55 Japan DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 56 China DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 57 China DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 58 China DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 59 India DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 60 India DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 61 India DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 62 South Korea DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 63 South Korea DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 64 South Korea DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 65 Australia DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 66 Australia DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 67 Australia DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 68 Thailand DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 69 Thailand DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 70 Thailand DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 71 Latin America DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
• Table 72 Latin America DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 73 Latin America DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 74 Latin America DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 75 Brazil DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 76 Brazil DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 77 Brazil DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 78 Argentina DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 79 Argentina DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 80 Argentina DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 81 Middle East and Africa DNA Microarray Market, By Country, 2018 - 2030 (USD Million)
• Table 82 Middle East and Africa DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 83 Middle East and Africa DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 84 Middle East and Africa DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 85 South Africa DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 86 South Africa DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 87 South Africa DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 90 Saudi Arabia DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 91 UAE DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 92 UAE DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 93 UAE DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)
• Table 94 Kuwait DNA Microarray Market, By Type, 2018 - 2030 (USD Million)
• Table 95 Kuwait DNA Microarray Market, By Application, 2018 - 2030 (USD Million)
• Table 96 Kuwait DNA Microarray Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 DNA microarray market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2024)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 DNA Microarray market: Type movement analysis
• Fig. 17 DNA Microarray market: Type segment dashboard
• Fig. 18 DNA Microarray market Type outlook: Key takeaways
• Fig. 19 Complementary DNA microarrays market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Oligonucleotide DNA microarrays market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 DNA Microarray market: Application movement analysis
• Fig. 22 DNA Microarray market: Application segment dashboard
• Fig. 23 DNA Microarray market Application outlook: Key takeaways
• Fig. 24 Gene expression analysis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Genotyping market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 DNA Microarray market: End Use movement analysis
• Fig. 28 DNA Microarray market: End Use segment dashboard
• Fig. 29 DNA Microarray market End Use outlook: Key takeaways
• Fig. 30 Pharmaceutical and biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Hospitals and clinics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Academic and research institute market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Regional outlook, 2024 & 2030
• Fig. 36 Regional market dashboard
• Fig. 37 Regional market place: Key takeaways
• Fig. 38 North America, SWOT
• Fig. 39 Europe, SWOT
• Fig. 40 Asia Pacific, SWOT
• Fig. 41 Latin America, SWOT
• Fig. 42 Middle East and Africa, SWOT
• Fig. 43 North America
• Fig. 44 North America DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 45 U.S.
• Fig. 46 U.S. DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 47 Canada
• Fig. 48 Canada DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 49 Europe
• Fig. 50 Europe DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 51 UK.
• Fig. 52 UK DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 53 Germany
• Fig. 54 Germany DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 55 Spain
• Fig. 56 Spain DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 57 France
• Fig. 58 France DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 59 Italy
• Fig. 60 Italy DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 61 Denmark
• Fig. 62 Denmark DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 63 Norway
• Fig. 64 Norway DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 65 Sweden
• Fig. 66 Sweden DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 67 Asia Pacific
• Fig. 68 Asia Pacific DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 69 Japan
• Fig. 70 Japan DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 71 China
• Fig. 72 China DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 73 India
• Fig. 74 India DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 75 South Korea
• Fig. 76 South Korea DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 77 Australia
• Fig. 78 Australia DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 79 Thailand
• Fig. 80 Thailand DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 81 Latin America
• Fig. 82 Latin America DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 83 Brazil
• Fig. 84 Brazil DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 85 Mexico
• Fig. 86 Mexico DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 87 Argentina
• Fig. 88 Argentina DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 89 Middle East and Africa
• Fig. 90 MEA DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 91 South Africa
• Fig. 92 South Africa DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 93 Saudi Arabia
• Fig. 94 Saudi Arabia DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 95 UAE
• Fig. 96 UAE DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 97 Kuwait
• Fig. 98 Kuwait DNA microarray market, 2018 - 2030 (USD Million)
• Fig. 99 Strategy Mapping

DNA Microarray Market Growth & Trends:

The global DNA microarray market size is expected to reach USD 3.53 billion by 2030, registering CAGR of 8.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The DNA microarray market is anticipated to witness exponential growth opportunities owing to the technological advancements and rising R&D investments by the leading participants. In addition, the increasing adoption of DNA microarray technologies in various applications such as genetic disease diagnosis, cancer research, and personalized medicine are the leading factors propelling the global market.

Rapid and accurate disease diagnosis is very crucial for the appropriate treatment of the patients. The recent advances in molecular-level interaction & detection technologies are upgrading clinical diagnostics services by offering novel solutions for diagnosis. Likewi se, the recent advancements in diagnostic DNA microarrays have opened new avenues for the market stakeholders. The DNA microarray technique has applications in genotyping, disease diagnosis, detecting abnormalities, and screening nucleotide polymorphisms.

Moreover, the global DNA microarray market is anticipated to witness exponential growth opportunities owing to the increased research funding, rising healthcare costs, technological advancements, and increased demand for the precision and tailored therapeutic solutions. For instance, according to Med City INVEST Precision Medicine, consumers are increasingly aware of the specific therapies, including precision therapy for treating chronic diseases.

In addition, increased investments by the leading players in the production of effective and advanced diagnostic tools and various strategic initiatives undertaken by the market participants are likely to create new avenues for expansion. For instance, in September 2022, Illumina, Inc. announced the launch of the NovaSeq X Series, a next-generation technology product that can produce more than 20,000 genomes per year. In addition, in September 2021, SCHOTT MINIFAB acquired an Arizona-based microarray solutions company. This acquisition is expected to help the company to strengthen its bioscience capabilities in the U.S.

DNA Microarray Market Report Highlights:

• The oligonucleotide DNA microarrays segment held the largest share owing to its cost-effectivity and higher capability to monitor the expression of every gene in the genome
• The complementary DNA microarrays segment is anticipated to register the fastest growth rate because of its wide range of applications in polymorphism screening, genomic DNA clones mapping, and gene discoveries
• The gene expression analysis segment accounted for the largest market in 2024 due to the adopting gene expression in different applications such as clinical diagnostics, drug discovery, microbiology, and other end-use applications
• Based on end user, the academic & research institute segment dominated the market in 2024, whereas the diagnostic centers segment is anticipated to be the fastest-growing during the forecast period
• Asia Pacific is expected to exhibit the fastest growth during the forecast period due to the surge in genomic research funding and increasing awareness about the genetic testing in the region.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 DNA Microarray Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market
• 3.2 Market Dynamics
  • 3.2.1 Market drivers analysis
    • 3.2.1.1 Increasing adoption of DNA microarray for various applications
    • 3.2.1.2 Increasing prevalence of genetic disorders and cancers
    • 3.2.1.3 Growing research activities
  • 3.2.2 Market restraint analysis
    • 3.2.2.1 High cost involved in the sequencing
    • 3.2.2.2 Availability of cost effetive alternative
• 3.3 Penetration & Growth Prospect Mapping
• 3.4 DNA Microarray: Market Analysis Tools
  • 3.4.1 Industry analysis - Porter's
  • 3.4.2 PESTLE analysis
• 3.5 Regulatory Framework

Chapter 4 DNA Microarray Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Type Market Share Analysis, 2022 & 2030
• 4.3 Segment Dashboard
• 4.4 Global DNA Microarray Market, by Type, 2018 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.5.1 Complementary DNA microarrays
    • 4.5.1.1 Complementary DNA microarraysmarket estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.2 Oligonucleotide DNA microarrays
    • 4.5.2.1 Oligonucleotide DNA microarraysmarket estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 DNA Microarray Market Segment Analysis, By Application 2018 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 Application Market Share Analysis, 2022 & 2030
• 5.3 Segment Dashboard
• 5.4 Global DNA Microarray Market, by Application, 2018 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5.1 Gene expression analysis
    • 5.5.1.1 Gene expression analysis market estimates and forecast, 2018 - 2030, (USD Million)
  • 5.5.2 Genotyping
    • 5.5.2.1 Genotyping market estimates and forecast, 2018 - 2030, (USD Million)
  • 5.5.3 Others
    • 5.5.5.1 Others estimates and forecast, 2018 - 2030, (USD Million)

Chapter 6 DNA Microarray Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 End Use Market Share Analysis, 2022 & 2030
• 6.3 Segment Dashboard
• 6.4 Global DNA Microarray Market, by End Use, 2018 to 2030
• 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 6.5.1 Pharmaceutical and biotechnology companies
    • 6.5.1.1 Pharmaceutical and biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.2 Diagnostic centers
    • 6.5.2.1 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3 Hospitals and clinics
    • 6.5.3.1 Hospitals and clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3 Academic and research institute
    • 6.5.3.1 Academic and research institute market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3 Others
    • 6.5.3.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 DNA Microarray Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 7.1 Definition & Scope
• 7.2 Regional Market Share Analysis, 2022 & 2030
• 7.3 Regional Market Dashboard
• 7.4 Regional Market Snapshot
• 7.5 SWOT Analysis
  • 7.5.1 North America
  • 7.5.2 Europe
  • 7.5.3 Asia Pacific
  • 7.5.4 Latin America
  • 7.5.5 Middle East & Africa
• 7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
  • 7.6.1 North America
    • 7.6.1.1 North America DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.1.2 U.S.
      • 7.6.1.2.1 Key Country Dynamics
      • 7.6.1.2.2 Competitive Scenario
      • 7.6.1.2.3 Regulatory Framework
      • 7.6.1.2.4 Reimbursement Scenario
      • 7.6.1.2.5 U.S. DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.1.3 Canada
      • 7.6.1.3.1 Key Country Dynamics
      • 7.6.1.3.2 Competitive Scenario
      • 7.6.1.3.3 Regulatory Framework
      • 7.6.1.3.4 Reimbursement Scenario
      • 7.6.1.3.5 Canada DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.1.4 Mexico
      • 7.6.1.4.1 Key Country Dynamics
      • 7.6.1.4.2 Competitive Scenario
      • 7.6.1.4.3 Regulatory Framework
      • 7.6.1.4.4 Reimbursement Scenario
      • 7.6.1.4.5 Mexico DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.2 Europe
    • 7.6.2.1 Europe DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.2 UK
      • 7.6.2.2.1 Key Country Dynamics
      • 7.6.2.2.2 Competitive Scenario
      • 7.6.2.2.3 Regulatory Framework
      • 7.6.2.2.4 Reimbursement Scenario
      • 7.6.2.2.5 UK DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.3 Germany
      • 7.6.2.3.1 Key Country Dynamics
      • 7.6.2.3.2 Competitive Scenario
      • 7.6.2.3.3 Regulatory Framework
      • 7.6.2.23.4 Reimbursement Scenario
      • 7.6.2.3.5 Germany DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.4 Spain
      • 7.6.2.4.1 Key Country Dynamics
      • 7.6.2.4.2 Competitive Scenario
      • 7.6.2.4.3 Regulatory Framework
      • 7.6.2.4.4 Reimbursement Scenario
      • 7.6.2.4.5 Spain DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.5 France
      • 7.6.2.5.1 Key Country Dynamics
      • 7.6.2.5.2 Competitive Scenario
      • 7.6.2.5.3 Regulatory Framework
      • 7.6.2.5.4 Reimbursement Scenario
      • 7.6.2.5.5 France DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.6 Italy
      • 7.6.2.6.1 Key Country Dynamics
      • 7.6.2.6.2 Competitive Scenario
      • 7.6.2.6.3 Regulatory Framework
      • 7.6.2.6.4 Reimbursement Scenario
      • 7.6.2.6.5 Italy DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.7 Denmark
      • 7.6.2.7.1 Key Country Dynamics
      • 7.6.2.7.2 Competitive Scenario
      • 7.6.2.7.3 Regulatory Framework
      • 7.6.2.7.4 Reimbursement Scenario
      • 7.6.2.7.5 Denmark DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.8 Sweden
      • 7.6.2.8.1 Key Country Dynamics
      • 7.6.2.8.2 Competitive Scenario
      • 7.6.2.8.3 Regulatory Framework
      • 7.6.2.8.4 Reimbursement Scenario
      • 7.6.2.8.5 Sweden DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.9 Norway
      • 7.6.2.9.1 Key Country Dynamics
      • 7.6.2.9.2 Competitive Scenario
      • 7.6.2.9.3 Regulatory Framework
      • 7.6.2.9.4 Reimbursement Scenario
      • 7.6.2.9.5 Norway DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3 Asia Pacific
    • 7.6.3.1 Asia Pacific DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.2 Japan
      • 7.6.3.2.1 Key Country Dynamics
      • 7.6.3.2.2 Competitive Scenario
      • 7.6.3.2.3 Regulatory Framework
      • 7.6.3.2.4 Reimbursement Scenario
      • 7.6.3.2.5 Japan DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.3 China
      • 7.6.3.3.1 Key Country Dynamics
      • 7.6.3.3.2 Competitive Scenario
      • 7.6.3.3.3 Regulatory Framework
      • 7.6.3.3.4 Reimbursement Scenario
      • 7.6.3.3.5 China DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.4 India
      • 7.6.3.4.1 Key Country Dynamics
      • 7.6.3.4.2 Competitive Scenario
      • 7.6.3.4.3 Regulatory Framework
      • 7.6.3.4.4 Reimbursement Scenario
      • 7.6.3.4.5 India DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.5 South Korea
      • 7.6.3.5.1 Key Country Dynamics
      • 7.6.3.5.2 Competitive Scenario
      • 7.6.3.5.3 Regulatory Framework
      • 7.6.3.5.4 Reimbursement Scenario
      • 7.6.3.5.5 South Korea DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.6 Australia
      • 7.6.3.6.1 Key Country Dynamics
      • 7.6.3.6.2 Competitive Scenario
      • 7.6.3.6.3 Regulatory Framework
      • 7.6.3.6.4 Reimbursement Scenario
      • 7.6.3.6.5 Australia DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.7 Thailand
      • 7.6.3.7.1 Key Country Dynamics
      • 7.6.3.7.2 Competitive Scenario
      • 7.6.3.7.3 Regulatory Framework
      • 7.6.3.7.4 Reimbursement Scenario
      • 7.6.3.7.5 Thailand DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.4 Latin America
    • 7.6.4.1 Latin America DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4.2 Brazil
      • 7.6.4.2.1 Key Country Dynamics
      • 7.6.4.2.2 Competitive Scenario
      • 7.6.4.2.3 Regulatory Framework
      • 7.6.4.2.4 Reimbursement Scenario
      • 7.6.4.2.5 Brazil DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4.4 Argentina
      • 7.6.4.4.1 Key Country Dynamics
      • 7.6.4.4.2 Competitive Scenario
      • 7.6.4.4.3 Regulatory Framework
      • 7.6.4.4.4 Reimbursement Scenario
      • 7.6.4.4.5 Argentina DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.5 MEA
    • 7.6.5.1 MEA DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5.2 South Africa
      • 7.6.5.2.1 Key Country Dynamics
      • 7.6.5.2.2 Competitive Scenario
      • 7.6.5.2.3 Regulatory Framework
      • 7.6.5.2.4 Reimbursement Scenario
      • 7.6.5.2.5 South Africa DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5.3 Saudi Arabia
      • 7.6.5.3.1 Key Country Dynamics
      • 7.6.5.3.2 Competitive Scenario
      • 7.6.5.3.3 Regulatory Framework
      • 7.6.5.3.4 Reimbursement Scenario
      • 7.6.5.3.5 Saudi Arabia DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5.4 UAE
      • 7.6.5.4.1 Key Country Dynamics
      • 7.6.5.4.2 Competitive Scenario
      • 7.6.5.4.3 Regulatory Framework
      • 7.6.5.4.4 Reimbursement Scenario
      • 7.6.5.4.5 UAE DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5.5 Kuwait
      • 7.6.5.5.1 Key Country Dynamics
      • 7.6.5.5.2 Competitive Scenario
      • 7.6.5.5.3 Regulatory Framework
      • 7.6.5.5.4 Reimbursement Scenario
      • 7.6.5.5.5 Kuwait DNA microarray market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 DNA Microarray Market - Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.1.1 Ansoff matrix
  • 8.1.2 Heat map analysis
  • 8.1.3 Major Deals and Strategic Alliances Analysis
    • 8.1.3.1 Joint Ventures
    • 8.1.3.2 Licensing Agreements
    • 8.1.3.3 Product Launches
    • 8.1.3.1 Conferences and Campaigns
• 8.2 Company Categorization
  • 8.2.1 Innovators
  • 8.2.2 Market Leaders
• 8.3 Vendor Landscape
  • 8.3.1 List of key distributors and channel partners
  • 8.3.2 Key customers
• 8.4 Public Companies
  • 8.4.1 Competitive Dashboard Analysis
    • 8.4.1.1 Market Differentiators
• 8.5 Private Companies
  • 8.5.1 List of key emerging companies
• 8.6 Company Profiles
  • 8.6.1 QIAGEN
    • 8.6.1.1 Company overview
    • 8.6.1.2 Financial performance
    • 8.6.1.3 Product benchmarking
    • 8.6.1.4 Strategic Initiatives
  • 8.6.2 Illumina, Inc.
    • 8.6.2.1 Company overview
    • 8.6.2.2 Financial performance
    • 8.6.2.3 Product benchmarking
    • 8.6.2.4 Strategic Initiatives
  • 8.6.3 Merck KGaA
    • 8.6.3.1 Company overview
    • 8.6.3.2 Financial performance
    • 8.6.3.3 Product benchmarking
    • 8.6.3.4 Strategic Initiatives
  • 8.6.4 Thermo Fisher Scientific, Inc.
    • 8.6.4.1 Company overview
    • 8.6.4.2 Financial performance
    • 8.6.4.3 Product benchmarking
    • 8.6.4.4 Strategic Initiatives
  • 8.6.5 BIOMERIEUX
    • 8.6.5.1 Company overview
    • 8.6.5.2 Financial performance
    • 8.6.5.3 Product benchmarking
    • 8.6.5.4 Strategic Initiatives
  • 8.6.6 Agilent Technologies, Inc.
    • 8.6.6.1 Company overview
    • 8.6.6.2 Financial performance
    • 8.6.6.3 Product benchmarking
    • 8.6.6.4 Strategic Initiatives
  • 8.6.7 F. Hoffmann-La Roche Ltd.
    • 8.6.7.1 Company overview
    • 8.6.7.2 Financial performance
    • 8.6.7.3 Product benchmarking
    • 8.6.7.4 Strategic initiatives
  • 8.6.8 PerkinElmer, Inc.
    • 8.6.8.1 Company overview
    • 8.6.8.2 Financial performance
    • 8.6.8.3 Product benchmarking
    • 8.6.8.4 Strategic initiatives
  • 8.6.9 Applied Micro Arrays
    • 8.6.9.1 Company overview
    • 8.6.9.2 Financial performance
    • 8.6.9.3 Product benchmarking
    • 8.6.9.4 Strategic initiatives